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LETTERS TO THE EDITOR
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stage renal disease, and anti-HCV-positive patients under- Togo (West Africa), where S-hemoglobins represent
more than 60% of all hemoglobins investigated by elec-went transplantation in a significantly lesser proportion
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tained 20 to 25 erythrocytes per high power field (4003),result on mortality, because life expectancy is better in
several of which were clearly sickled. The presence of atransplanted patients than in patients continuing dialysis.
sickle cell disease was confirmed by the Emmel test, whichIn addition, in Pereira’s study the major death risk factor
showed a 100% sickling of the peripheral erythrocytesin HCV-positive patients was infection, rather than liver
after their incubation for 30 minutes with soda meta-disease. Espinosa et al agree with us that histological le-
bisulphite.sions of the liver are mild and that liver disease shows
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Reply from the authorsDiagnosing sickle cell disease
The urinary findings described in our paper pertain toTo the Editor: I read with interest the recent review
patients who carry the diagnosis of sickle cell disease.
article by Pham et al about the renal abnormalities in
Hematuria is one of the renal abnormalities seen in sickle
sickle cell disease [1]. In describing hematuria caused by cell disease.
this condition, however, the authors missed a point which We did not describe the red blood cell morphology
in my opinion is important. In fact, they did not mention because it is not always the same. Depending on where
that sickled erythrocytes can be found in the urine of red blood cells enter the genital urinary tract and the
patients with sickle cell disease, a finding which can be of status of the sickle cell disease, the red blood cell mor-
diagnostic importance. This fact has been stressed in a phology may run the spectrum from normal to dysmor-
recent paper, which described how the diagnosis of sickle phic to sickle cell shaped.
cell disease can be suggested by the finding in the urinary We do not disagree that the presence of urinary sickle
sediment of sickled erythrocytes [2], and has also been cell-shaped red blood cells may be seen in patients with
reported in other studies [3–7]. sickle cell disease. However, the diagnosis of sickle cell
Besides the case described [2], I have seen urinary sickled disease is generally made by hemoglobin electrophoresis.
This latter point was noted in references [2–4] quotederythrocytes again recently, while examining the urinary
in the letter to the editor.sediments at the Hospital of St. Jean de Dieu of Afagnan,
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